Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 109.82M | $ 69.48M | $ 0 | -63.27% |
3/31/2025 | $ 43.31M | $ 69.44M | $ 0 | -160.34% |
12/31/2024 | $ 87.72M | $ 185.07M | $ 0 | -210.97% |
9/30/2024 | $ 134.19M | $ 115.63M | $ 0 | -86.17% |
6/30/2024 | $ 10.24M | $ 141.56M | $ 0 | -1382.76% |
3/31/2024 | $ 11.19M | $ 148.16M | $ 0 | -1324.15% |
12/31/2023 | $ 22.49M | $ 46.29M | $ 0 | -205.79% |
9/30/2023 | $ 18.85M | $ 46.37M | $ 0 | -245.93% |
6/30/2023 | $ 4.01M | $ 20.43M | $ 0 | -510.02% |
3/31/2023 | $ 37.23M | $ 13.86M | $ 0 | -37.22% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for AVALO THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 45.31M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 154.31M ]
(=) Payout Yield [ -29.36% ]
Minimum
Jun 30, 2024
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.34% |
std | 5.11% |